Welch & Forbes LLC West Pharmaceutical Services Inc Transaction History

Welch & Forbes LLC

$8.21 Billion
Q3 2025

A detailed history of Welch & Forbes LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Welch & Forbes LLC holds 3,007 shares of WST stock, worth $785,909. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,007

Previous 4,146 27.47%

Holding current value

$785,909

Previous $907,000 13.12%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$210.08 - $279.1 $239,281 - $317,894	-1,139 Reduced 27.47%	3,007 $788,000
Q2 2025 Aug 04, 2025	SELL	$190.39 - $227.7 $568,885 - $680,367	-2,988 Reduced 41.88%	4,146 $907,000
Q1 2025 May 02, 2025	SELL	$199.11 - $347.87 $266,210 - $465,102	-1,337 Reduced 15.78%	7,134 $1.6 Million
Q4 2024 Feb 06, 2025	SELL	$285.69 - $344.0 $187,412 - $225,664	-656 Reduced 7.19%	8,471 $2.77 Million
Q3 2024 Nov 04, 2024	BUY	$277.16 - $333.3 $95,065 - $114,321	343 Added 3.9%	9,127 $2.74 Million

Q2 2024 Aug 01, 2024	BUY	$314.68 - $395.94 $832,643 - $1.05 Million	2,646 Added 43.11%	8,784 $2.89 Million
Q1 2024 May 02, 2024	BUY	$338.27 - $413.0 $813,201 - $992,852	2,404 Added 64.38%	6,138 $2.43 Million
Q4 2023 Feb 06, 2024	BUY	$318.29 - $392.21 $173,468 - $213,754	545 Added 17.09%	3,734 $1.31 Million
Q3 2023 Nov 02, 2023	BUY	$354.9 - $412.41 $138,056 - $160,427	389 Added 13.89%	3,189 $1.2 Million
Q2 2023 Jul 28, 2023	BUY	$334.63 - $382.47 $630,442 - $720,573	1,884 Added 205.68%	2,800 $1.07 Million
Q1 2023 Apr 14, 2023	BUY	$232.5 - $346.47 $212,970 - $317,366	916 New	916 $317,000

Others Institutions Holding WST

# of Institutions

852

Shares Held

68.1M

Call Options Held

285K

Put Options Held

106K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $19.3B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account